Quantifying the value of stroke disability outcomes: Who global burden of disease project disability weights for each level of the modified rankin scale

Stroke

Volumn 40, Issue 12, 2009, Pages 3828-3833

  Hong, Keun Sik ^a   Saver, Jeffrey L ^b  

^a Inje University   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Disability weight; Modified Rankin Scale; Person trade off; Stroke outcome

Indexed keywords

ARTICLE; DISABILITY; DISEASE SEVERITY; HEALTH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANKIN SCALE; STROKE; WORLD HEALTH ORGANIZATION;

ACTIVITIES OF DAILY LIVING; COST OF ILLNESS; DATA INTERPRETATION, STATISTICAL; DISABILITY EVALUATION; DISABLED PERSONS; HUMANS; LENGTH OF STAY; OBSERVER VARIATION; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT CARE TEAM; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; STROKE; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 73449109821     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.561365     Document Type: Article

References (23)

1. Solomon NA, Glick HA, Russo CJ, Lee J, Schulman KA. Patient preferences for stroke outcomes. Stroke. 1994;25:1721-1725.
2. Gage BF, Cardinalli AB, Albers GW, Owens DK. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA. 1995;274:1839-1845.
3. Hallan S, Asberg A, Indredavik B, Wideroe TE. Quality of life after cerebrovascular stroke: a systematic study of patients' preferences for different functional outcomes. J Intern Med. 1999;246:309-316.
4. Curriculum Directory. American Association of Medical Colleges. Available at http://services.aamc.org/currdir/. Last accessed June 22, 2009
5. - 2009 USMLE Bulletin-Examination Content. Available at http:// www.usmle.org/General-Information/bulletin/2009/content.html. Last accessed June 22, 2009.
6. Murray CJ. Rethinking DALYs, in The Global Burden of Disease, Murray CJL, Lopez AD, eds. Global Burden of Disease and Injury Series. Cambridge, Mass: Harvard University Press; 1996;1:1-98.
7. Nord E. Methods for quality adjustment of life years. Soc Sci Med. 1992;34:559-569.
8. Nord E. The person-trade-off approach to valuing health care programs. Med Decis Making. 1995;15:201-208.
9. Richardson J, Nord E. The importance of perspective in the measurement of quality-adjusted life years. Med Decis Making. 1997;17:33-41.
10. Stouthard MEA, Essink-Bot ML, Bonsel GJ. Disability weights for diseases: a modified protocol and results for a Western European region. Eur J Public Health. 2000;10:24-30.
11. Jones J, Hunter D. Consensus methods for medical and health services research. BMJ. 1995;311:376-380.
12. English JM, Kernan GL. Stability and agreement criteria for the termination of Delphi studies. Technol Forecasting Soc Change. 1976;13: 83-90.
13. WHO. Global Burden of Disease 2004 Update: Disability Weights for Diseases and Conditions. 2008. Available at www.who.int/healthinfo/ global-burden-disease/GBD2004-DisabilityWeights.pdf). Last accessed April 2, 2009.
14. Kleindorfer D, Broderick J, Khoury J, Flaherty M, Woo D, Alwell K, Moomaw CJ, Schneider A, Miller R, Shukla R, Kissela B. The unchanging incidence and case-fatality of stroke in the 1990s: a population-based study. Stroke. 2006;37:2473-2478. (Pubitemid 44454663)
15. Jiang B, Wang WZ, Chen H, Hong Z, Yang QD, Wu SP, Du XL, Bao QJ. Incidence and trends of stroke and its subtypes in China: results from three large cities. Stroke. 2006;37:63-68.
16. Savitz SI, Benatar M, Saver JL, Fisher M. Outcome analysis in clinical trial design for acute stroke: physicians' attitudes and choices. Cerebrovasc Dis. 2008;26:156-162.
17. Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hardemark HG, Wasiewski WW. NXY-059 for acute ischemic stroke. N Engl J Med. 2006;354:588-600.
18. Post PN, Stiggelbout AM, Wakker PP. The utility of health states after stroke: a systematic review of the literature. Stroke. 2001;32: 1425-1429.
19. Dawson J, Lees JS, Chang TP, Walters MR, Ali M, Davis SM, Diener HC, Lees KR. Association between disability measures and healthcare costs after initial treatment for acute stroke. Stroke. 2007;38: 1893-1898.
20. Eriksson M, Norrving B, Terent A, Stegmayr B. Functional outcome 3 months after stroke predicts long-term survival. Cerebrovasc Dis. 2008; 25:423-429.
21. Samsa GP, Reutter RA, Parmigiani G, Ancukiewicz M, Abrahamse P, Lipscomb J, Matchar DB. Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke. J Clin Epidemiol. 1999;52:259-271.
22. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
23. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, Montaner J, Saqqur M, Demchuk AM, Moye LA, Hill MD, Wojner AW. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med. 2004;351:2170-2178.